Ishii, H., Azuma, K., Sakai, K., Naito, Y., Matsuo, N., Tokito, T., . . . Nishio, K. (2020). Determination of Somatic Mutations and Tumor Mutation Burden in Plasma by CAPP-Seq during Afatinib Treatment in NSCLC Patients Resistance to Osimertinib. Sci Rep.
Chicago Style CitationIshii, Hidenobu, Koichi Azuma, Kazuko Sakai, Yoshiko Naito, Norikazu Matsuo, Takaaki Tokito, Kazuhiko Yamada, Tomoaki Hoshino, i Kazuto Nishio. "Determination of Somatic Mutations and Tumor Mutation Burden in Plasma By CAPP-Seq During Afatinib Treatment in NSCLC Patients Resistance to Osimertinib." Sci Rep 2020.
Cita MLAIshii, Hidenobu, et al. "Determination of Somatic Mutations and Tumor Mutation Burden in Plasma By CAPP-Seq During Afatinib Treatment in NSCLC Patients Resistance to Osimertinib." Sci Rep 2020.